These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 33779064)
21. Pegloticase Treatment Significantly Decreases Blood Pressure in Patients With Chronic Gout. Johnson RJ; Choi HK; Yeo AE; Lipsky PE Hypertension; 2019 Jul; 74(1):95-101. PubMed ID: 31079535 [TBL] [Abstract][Full Text] [Related]
22. Effect of allopurinol on the glomerular filtration rate of children with chronic kidney disease. Ghane Sharbaf F; Assadi F Pediatr Nephrol; 2018 Aug; 33(8):1405-1409. PubMed ID: 29549464 [TBL] [Abstract][Full Text] [Related]
23. The effect of the addition of allopurinol on blood pressure control in African Americans treated with a thiazide-like diuretic. Segal MS; Srinivas TR; Mohandas R; Shuster JJ; Wen X; Whidden E; Tantravahi J; Johnson RJ J Am Soc Hypertens; 2015 Aug; 9(8):610-619.e1. PubMed ID: 26140739 [TBL] [Abstract][Full Text] [Related]
24. Impaired arterial responsiveness in untreated gout patients compared with healthy non-gout controls: association with serum urate and C-reactive protein. Krasnokutsky S; Romero AG; Bang D; Pike VC; Shah B; Igel TF; Dektiarev I; Guo Y; Zhong J; Katz SD; Pillinger MH Clin Rheumatol; 2018 Jul; 37(7):1903-1911. PubMed ID: 29450849 [TBL] [Abstract][Full Text] [Related]
25. Effect of uric acid-lowering therapy on blood pressure: systematic review and meta-analysis. Qu LH; Jiang H; Chen JH Ann Med; 2017 Mar; 49(2):142-156. PubMed ID: 27689859 [TBL] [Abstract][Full Text] [Related]
26. Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study. Schumacher HR; Evans RR; Saag KG; Clower J; Jennings W; Weinstein SP; Yancopoulos GD; Wang J; Terkeltaub R Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1462-70. PubMed ID: 22549879 [TBL] [Abstract][Full Text] [Related]
28. Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes. Doria A; Galecki AT; Spino C; Pop-Busui R; Cherney DZ; Lingvay I; Parsa A; Rossing P; Sigal RJ; Afkarian M; Aronson R; Caramori ML; Crandall JP; de Boer IH; Elliott TG; Goldfine AB; Haw JS; Hirsch IB; Karger AB; Maahs DM; McGill JB; Molitch ME; Perkins BA; Polsky S; Pragnell M; Robiner WN; Rosas SE; Senior P; Tuttle KR; Umpierrez GE; Wallia A; Weinstock RS; Wu C; Mauer M; N Engl J Med; 2020 Jun; 382(26):2493-2503. PubMed ID: 32579810 [TBL] [Abstract][Full Text] [Related]
29. Clinically insignificant effect of supplemental vitamin C on serum urate in patients with gout: a pilot randomized controlled trial. Stamp LK; O'Donnell JL; Frampton C; Drake JM; Zhang M; Chapman PT Arthritis Rheum; 2013 Jun; 65(6):1636-42. PubMed ID: 23681955 [TBL] [Abstract][Full Text] [Related]
30. Effect of Urate-Lowering Therapy on Cardiovascular and Kidney Outcomes: A Systematic Review and Meta-Analysis. Chen Q; Wang Z; Zhou J; Chen Z; Li Y; Li S; Zhao H; Badve SV; Lv J Clin J Am Soc Nephrol; 2020 Nov; 15(11):1576-1586. PubMed ID: 33055192 [TBL] [Abstract][Full Text] [Related]
31. The Effect of Lesinurad in Combination With Allopurinol on Serum Uric Acid Levels in Patients With Gout. Baumgartner S; Yeh LT; Shen Z; Kerr B; Manhard K; Quart B J Clin Pharmacol; 2018 Sep; 58(9):1164-1170. PubMed ID: 29733441 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients. Hanvivadhanakul P; Akkasilpa S; Deesomchok U J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S40-7. PubMed ID: 12188443 [TBL] [Abstract][Full Text] [Related]
33. Whey protein lowers blood pressure and improves endothelial function and lipid biomarkers in adults with prehypertension and mild hypertension: results from the chronic Whey2Go randomized controlled trial. Fekete ÁA; Giromini C; Chatzidiakou Y; Givens DI; Lovegrove JA Am J Clin Nutr; 2016 Dec; 104(6):1534-1544. PubMed ID: 27797709 [TBL] [Abstract][Full Text] [Related]
34. Impact of urate-lowering drugs on the progression and recovery from chronic kidney disease among gout patients. Chung TT; Yu KH; Kuo CF; Luo SF; Chiou MJ; Lan WC; Chen JS; Tseng WY; Hsieh AH; Wang LC Arthritis Res Ther; 2019 Sep; 21(1):210. PubMed ID: 31533805 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout. Perez-Ruiz F; Alonso-Ruiz A; Calabozo M; Herrero-Beites A; García-Erauskin G; Ruiz-Lucea E Ann Rheum Dis; 1998 Sep; 57(9):545-9. PubMed ID: 9849314 [TBL] [Abstract][Full Text] [Related]
36. Benefits of Allopurinol Treatment on Blood Pressure and Renal Function in Patients with Early Stage of Chronic Kidney Disease. Satirapoj B; Wirajit O; Burata A; Supasyndh O; Ruangkanchanasetr P J Med Assoc Thai; 2015 Dec; 98(12):1155-61. PubMed ID: 27004299 [TBL] [Abstract][Full Text] [Related]
37. Low-Dose Allopurinol Promotes Greater Serum Urate Lowering in Gout Patients with Chronic Kidney Disease Compared with Normal Kidney Function. Toprover M; Crittenden DB; Modjinou DV; Oh C; Krasnokutsky S; Fisher MC; Keenan RT; Pillinger MH Bull Hosp Jt Dis (2013); 2019 Mar; 77(2):87-91. PubMed ID: 31140959 [TBL] [Abstract][Full Text] [Related]
38. Effects of Dietary Patterns on Serum Urate: Results From a Randomized Trial of the Effects of Diet on Hypertension. Juraschek SP; Yokose C; McCormick N; Miller ER; Appel LJ; Choi HK Arthritis Rheumatol; 2021 Jun; 73(6):1014-1020. PubMed ID: 33615722 [TBL] [Abstract][Full Text] [Related]
39. A Randomized Pilot Study of DASH Patterned Groceries on Serum Urate in Individuals with Gout. Juraschek SP; Miller ER; Wu B; White K; Charleston J; Gelber AC; Rai SK; Carson KA; Appel LJ; Choi HK Nutrients; 2021 Feb; 13(2):. PubMed ID: 33562216 [TBL] [Abstract][Full Text] [Related]
40. Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: randomized, multicenter, double-blind, placebo-controlled, parallel-group, confirmatory phase 2 study. Hosoya T; Sano T; Sasaki T; Fushimi M; Ohashi T Clin Exp Nephrol; 2020 Mar; 24(Suppl 1):53-61. PubMed ID: 31792640 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]